SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 233 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $353,338 | +41.3% | 12,818 | +54.0% | 0.00% | – |
| Q2 2023 | $250,101 | -16.3% | 8,322 | +0.9% | 0.00% | -100.0% |
| Q1 2023 | $298,878 | +0.3% | 8,251 | -1.1% | 0.00% | 0.0% |
| Q4 2022 | $297,937 | -63.0% | 8,345 | -65.0% | 0.00% | -50.0% |
| Q3 2022 | $806,000 | +534.6% | 23,840 | +438.5% | 0.00% | – |
| Q2 2022 | $127,000 | -8.0% | 4,427 | +4.0% | 0.00% | – |
| Q1 2022 | $138,000 | +7.8% | 4,258 | -3.0% | 0.00% | – |
| Q4 2021 | $128,000 | +19.6% | 4,389 | +9.2% | 0.00% | – |
| Q3 2021 | $107,000 | -17.1% | 4,019 | -3.5% | 0.00% | – |
| Q2 2021 | $129,000 | +24.0% | 4,164 | +4.2% | 0.00% | – |
| Q1 2021 | $104,000 | +173.7% | 3,995 | +169.8% | 0.00% | – |
| Q4 2020 | $38,000 | -56.3% | 1,481 | -64.4% | 0.00% | – |
| Q3 2020 | $87,000 | -8.4% | 4,161 | +3.1% | 0.00% | – |
| Q2 2020 | $95,000 | +50.8% | 4,037 | +15.1% | 0.00% | – |
| Q1 2020 | $63,000 | – | 3,508 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |